Clinical Trial Update: A Dose-Escalation Study in Participants With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study in participants with advanced cancer has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Eli Lilly and Company | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED | Results posted: 2019-04-01